Analysis of Influencing Factors of Compliance with Non-Vitamin K Antagonist Oral Anticoagulant in Patients with Nonvalvular Atrial Fibrillation and Correlation with the Severity of Ischemic Stroke

Table 2

Univariate analysis of influencing compliance with NOACs (n, %, ).

Clinical information	Good compliance group (n = 59)	Poor compliance group (n = 87)	χ^2/t
Gender
Male	35 (59.3)	50 (57.5)	0.050	0.824
Female	24 (40.7)	37 (42.5)
Age
<65 years	41 (69.5)	40 (75.5)	7.870	0.001
≥65 years	18 (30.5)	47 (72.3)
Educational background
No educational background/primary school	28 (47.5)	18 (20.7)	16.350	≤0.001
Middle school/high school	18 (30.5)	40 (46.0)
University or above	9 (15.3)	33 (37.9)
Place of residence
Rural area	49 (83.1)	18 (20.7)	55.062	≤0.001
Cities and towns	10 (16.9)	69 (79.3)
Marriage situation
Unmarried/widowed	36 (61.0)	33 (37.93)	7.518	0.006
Married	23 (29.87)	54 (70.13)
Smoking history
Yes	25 (42.4)	26 (29.9)	2.412	0.120
No	34 (57.6)	61 (70.1)
Drinking history
Yes	18 (30.5)	33 (37.9)	0.852	0.356
No	41 (69.5)	54 (62.1)
Number of complications	2.6 ± 1.4	3.1 ± 0.9	2.627	0.012
Number of concomitant medications	4.3 ± 2.1	4.6 ± 2.2	0.823	0.412
CHA2DS2-VASc score
<2/3 (male/female)	40 (67.80)	5 (5.75)	63.484	≤0.001
≥2/3 (male/female)	19 (32.20)	82 (94.25)
HAS-BLED score
<3 score	51 (86.44)	16 (18.39)	49.313	≤0.001
≥3 score	8 (13.56)	51 (58.62)